Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mechanisms of plaque stabilization].

D Müller-Wieland1, M Faust, J Kotzka

  • 1Klinik II und Poliklinik für Innere Medizin, Universität zu Köln.

Herz
|March 27, 1999
PubMed
Summary

Aggressively lowering cholesterol reduces cardiovascular events by stabilizing atherosclerotic plaques, not just by widening arteries. This shift in understanding coronary heart disease focuses on plaque vulnerability and nature for better prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Juvenile nasopharyngeal angiofibroma: nationwide study on incidence, diagnosis, treatment, and recurrence.

Rhinology·2026
Same author

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial.

NPJ digital medicine·2021
Same author

Glycaemic Control in Diabetes.

Handbook of experimental pharmacology·2021
Same author

Salvage surgery for cervical radioiodine refractory 18F-FDG-PET positive recurrence of papillary thyroid cancer.

Endocrine connections·2021
Same author

The natural history of classic galactosemia: lessons from the GalNet registry.

Orphanet journal of rare diseases·2019
Same author

[Cardiovascular risk in gout patients : Cardiovascular Safety of Febuxostat or Allopurinol in Participants with Gout and Cardiovascular Comorbidities (CARES)].

Der Internist·2018

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Lipid Metabolism

Context:

  • Coronary heart disease prognosis is increasingly understood to depend on atherosclerotic plaque characteristics rather than stenosis severity alone.
  • Vulnerable plaques, defined by lipid-rich cores and thin fibrous caps, pose a high risk for rupture and acute coronary syndromes.
  • Statins may offer benefits beyond cholesterol reduction through direct effects on the vessel wall.

Purpose:

  • To explore the paradigm shift in understanding coronary heart disease from stenosis-centric to plaque-centric prognosis.
  • To investigate the multifaceted effects of lipid-lowering therapy on atherosclerotic plaque biology and endothelial function.
  • To highlight the potential for improved clinical characterization of plaque vulnerability for targeted prevention of acute coronary syndromes.

Summary:

  • Aggressive plasma cholesterol reduction significantly decreases cardiovascular complications, independent of changes in coronary luminal diameter.
  • Atherosclerotic plaque characteristics, particularly vulnerability, are key determinants of clinical prognosis.
  • Lipid-lowering therapies demonstrate pleiotropic effects, including plaque stabilization and improved endothelial function, contributing to early clinical benefits.

Impact:

  • Revises the understanding of cardiovascular disease management, emphasizing plaque stability over luminal diameter.
  • Suggests novel therapeutic strategies targeting plaque vulnerability to prevent acute coronary syndromes like myocardial infarction.
  • Provides a foundation for developing advanced diagnostic tools to assess and manage atherosclerotic plaque instability.

Related Experiment Videos